Conversely, MAP2K4 or ZDHHC17 knockdown TERT/CA-KRAS/DN-p53/ZDHHC17 hNSCs often resulted in smaller tumors, suggesting that ZDHHC17 contributes to glioma development. Here, TP53 is linked to central nervous system cancer.